Shanghai Conant Optical Co Ltd
HKEX:2276
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
6.04
15.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Shanghai Conant Optical Co Ltd
Cash from Financing Activities
Shanghai Conant Optical Co Ltd
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
S
|
Shanghai Conant Optical Co Ltd
HKEX:2276
|
Cash from Financing Activities
-ÂĄ212.4m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Cash from Financing Activities
-ÂĄ1.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Autobio Diagnostics Co Ltd
SSE:603658
|
Cash from Financing Activities
-ÂĄ1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-60%
|
CAGR 10-Years
N/A
|
||
Winner Medical Co Ltd
SZSE:300888
|
Cash from Financing Activities
-ÂĄ1.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Cash from Financing Activities
-ÂĄ568.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
||
Intco Medical Technology Co Ltd
SZSE:300677
|
Cash from Financing Activities
ÂĄ2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
Shanghai Conant Optical Co Ltd
Glance View
Shanghai Conant Optical Co., Ltd. engages in business of manufacturing and sale of resin spectacle lenses. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-12-16. The firm produces a variety of resin glasses, including standardized lenses and customized lenses. The firm's products are exported to the United States, Japan, India, Australia, Thailand, Germany, Brazil and other countries and regions.
See Also
What is Shanghai Conant Optical Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-212.4m
CNY
Based on the financial report for Dec 31, 2023, Shanghai Conant Optical Co Ltd's Cash from Financing Activities amounts to -212.4m CNY.
What is Shanghai Conant Optical Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-14%
Over the last year, the Cash from Financing Activities growth was 24%. The average annual Cash from Financing Activities growth rates for Shanghai Conant Optical Co Ltd have been -25% over the past three years , -14% over the past five years .